Skip to main content

Find Clinical Trials

Home
Conditions
Abruptio Placentae

Clinical trial condition

Abruptio Placentae

Explore clinical trials studying Abruptio Placentae. Study availability and eligibility vary by location and protocol.

14 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Abruptio Placentae trial results

Completed

Magnesium Sulfate vs Placebo for Placental Abruption

NCT00186069

Conditions: Abruptio Placentae, Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, +3 more
Locations: Santa Clara Valley Medical Center San Jose, California, United States

Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

NCT01068795

Conditions: Abruptio Placentae, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations: Dep. OB/GYN, HaEmek Medical Center Afula, Israel

View Trial Details

Completed

Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia

NCT00986765

Conditions: Abruptio Placentae, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death, +14 more
Locations: Centre Hospitalier Intercommunal de Créteil Créteil, France

View Trial Details

Completed

Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies

NCT01355822

Conditions: Abruptio Placentae, Death, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: University Hospital Jena, Department of Obstetrics Jena, Thuringia, Germany

View Trial Details